New research shows that genetic tests can now help predict which heart patients need higher doses of a common anti-clotting drug. Jessica Mega, HMS assistant professor of medicine at Brigham and Women’s Hospital, is the author of the study. Christopher Cannon, HMS associate professor of medicine at Brigham and Women’s Hospital, is also quoted.
Trending News
Research Provides Clues to Spleen’s Role in Coronary Artery Disease
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure